Outbreak spotlights safety of custom-mixed drugs
by Marilynn Marchione, AP Chief Medical Writer
October 04, 2012 01:45 PM | 962 views | 0 0 comments | 4 4 recommendations | email to a friend | print
A sign in front of the Waverly Business Center lists the New England Compounding and other business in Framingham, Mass., Wednesday Oct. 3, 2012. An outbreak of a rare and deadly form of meningitis has now sickened 26 people in five states who received steroid injections mostly for back pain, health officials said Wednesday. The Food and Drug Administration identified the maker of the steroid as New England Compounding Center, a specialty pharmacy. (AP Photo/Marshall Wolff, The MetroWest Daily News)
A sign in front of the Waverly Business Center lists the New England Compounding and other business in Framingham, Mass., Wednesday Oct. 3, 2012. An outbreak of a rare and deadly form of meningitis has now sickened 26 people in five states who received steroid injections mostly for back pain, health officials said Wednesday. The Food and Drug Administration identified the maker of the steroid as New England Compounding Center, a specialty pharmacy. (AP Photo/Marshall Wolff, The MetroWest Daily News)
slideshow
An unidentified man carries packages out of New England Compounding in Framingham, Mass., Thursday, Oct. 4, 2012. An outbreak of a rare and deadly form of fungal meningitis that has killed 4 people and sickened another 26 in five states is believed to have been traced back to a steroid manufactured by the New England Compounding Center. Investigators, though, say they are still trying to confirm the source of the infection. (AP Photo/Stephan Savoia)
An unidentified man carries packages out of New England Compounding in Framingham, Mass., Thursday, Oct. 4, 2012. An outbreak of a rare and deadly form of fungal meningitis that has killed 4 people and sickened another 26 in five states is believed to have been traced back to a steroid manufactured by the New England Compounding Center. Investigators, though, say they are still trying to confirm the source of the infection. (AP Photo/Stephan Savoia)
slideshow

Custom-mixed medicines like the steroid shots suspected in a meningitis outbreak have long been a source of concern, and their use is far wider than many people realize.

These medicines are made in private and hospital pharmacies and are used to treat everything from cancer to menopause symptoms to vision loss.

Often these products are name-brand medicines split into smaller doses, or drug combinations mixed from ingredients sold in bulk. That can easily lead to contamination if sterile conditions aren’t maintained. The germ suspected in the current outbreak can spread in the air.

A shortage of many drugs has forced doctors to stretch supplies and seek custom-made alternatives if the first-choice treatment was not available. The steroid suspected in the current outbreak has been in short supply.

"Because of the incredible number of drugs that are out of stock or back-ordered, compounding pharmacies are working with local hospitals, clinics and physicians to fill that gap," said David Miller, executive vice president of the International Academy of Compounding Pharmacists, a trade organization.

Drug shortages are one reason for the remarkable growth of these custom-made products. More than 7,500 compounding pharmacies operate in the United States, up from 5,000 in 2009, Miller said. They account for a $3 billion segment of the drug market and 3 percent of all prescriptions filled, he said.

Some say this industry needs more regulation.

"There’s not a lot of oversight of compounding pharmacies" compared to drug manufacturers, said Allen Vaida, executive vice president of the Institute for Safe Medication Practices, a suburban Philadelphia advocacy group that tracks medication errors.

The outbreak of fungal meningitis has sickened at least 26 people in five states. Four of them have died. They all received the steroid shots, mostly for back pain.

The Food and Drug Administration has said the steroid came from the New England Compounding Center, based in Framingham, Mass. The company recalled three lots of the drug last week and has said it has voluntarily suspended operations and is working with regulators to identify the source of the infection. Investigators also are looking into the antiseptic and anesthetic used during the injections.

___

Online: CDC and Trade group.

Comments
(0)
Comments-icon Post a Comment
No Comments Yet
*We welcome your comments on the stories and issues of the day and seek to provide a forum for the community to voice opinions. All comments are subject to moderator approval before being made visible on the website but are not edited. The use of profanity, obscene and vulgar language, hate speech, and racial slurs is strictly prohibited. Advertisements, promotions, and spam will also be rejected. Please read our terms of service for full guides